Evidence map›Paper›PMID 30519584›Full record

ArticleBioMed research international2018

Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux.

Shivapriya Shivakumar, Trailokyanath Panigrahi, Rohit Shetty, Murali Subramani, Arkasubhra Ghosh, Nallathambi Jeyabalan

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05947812 (A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05947812 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression (the "ACLR8-LR" Study)

TypeinterventionalSponsor60P Australia Pty LtdRan2023 to 2024Enrolled148ConditionsCOVID 19 Disease, Mild to Moderate COVID 19 Disease, SARS-CoV-2, Infectious DiseaseArmsTafenoquine Oral Tablet, Placebo
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Shiga Toxins Produced by EnterohaemorrhagicJournal of microbiology and biotechnology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Autophagy in the normal and diseased cornea.Experimental eye research · 2022
    Review
  13. Review
  14. Sjögren syndrome: looking forward to the future.Therapeutic advances in musculoskeletal disease · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shivapriya ShivakumarGROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, Karnataka, India.
Trailokyanath PanigrahiGROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, Karnataka, India.
Rohit ShettyDepartment of Cornea and Refractive surgery, Narayana Nethralaya Eye Hospital, Narayana Health City, Bommasandra, Bangalore, Karnataka, India.
Murali SubramaniGROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, Karnataka, India.
Arkasubhra GhoshGROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, Karnataka, India.ORCID 0000-0002-6570-5891
Nallathambi JeyabalanGROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, Karnataka, India.ORCID 0000-0001-7380-8762
Narayana Nethralaya · INNarayana Health · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dry eye disease (DED) is a multifactorial ocular surface disorder affecting millions of individuals worldwide. Inflammation has been associated with dry eye and anti-inflammatory drugs are now being targeted as the alternate therapeutic approach for dry eye condition. In this study, we have explored the anti-inflammatory and autophagy modulating effect of chloroquine (CQ) in human corneal epithelial and human corneal fibroblasts cells exposed to desiccation stress, (an

Indexed as

AutophagyChloroquineCorneaDry Eye SyndromesEpithelium, CornealHumansInflammationMatrix Metalloproteinase 9NF-kappa BPrimary Cell CultureProtective AgentsTumor Necrosis Factor-alphaChloroquineMatrix Metalloproteinase 9NF-kappa BProtective AgentsTumor Necrosis Factor-alpha

Identifiers

PMID30519584
PMCPMC6241345
OpenAlexW2898780944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.